Pendant Biosciences
Private Company
Total funding raised: $4.2M
Overview
Pendant Biosciences is an early-stage biotech innovator focused on creating highly tunable polymer systems for advanced drug delivery and biomedical surface coatings. Its core technology platform allows for the independent adjustment of multiple material properties—such as polymer molecular weight, cross-linking, porosity, and functionalization—to optimize drug loading, release kinetics, and biocompatibility. Operating as a private, likely pre-revenue platform company, Pendant Bio seeks to partner with therapeutic developers to create bespoke solutions for challenging drug candidates and medical devices. The company's success hinges on validating its platform through partnerships and advancing internal or collaborative programs toward clinical proof-of-concept.
Technology Platform
A next-generation, highly tunable polymer system for drug delivery and surface coatings. It allows for independent adjustment of parameters like polymer MW, monomer ratios, pendant functionalization, cross-linking, and porosity to precisely control drug loading, release kinetics, swelling, and mechanical properties.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Pendant Bio competes in the crowded advanced drug delivery sector against established formulation experts (e.g., Catalent, Lonza, Evonik), lipid nanoparticle specialists, and other polymer-focused startups. Its key claimed differentiation is the independent tunability of multiple material properties, a feature not easily achieved with conventional polymer systems.